| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.38e-05 | 18 | 71 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 1.24e-04 | 5 | 71 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.32e-04 | 28 | 71 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.07e-04 | 37 | 71 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 3.44e-04 | 8 | 71 | 2 | GO:0101021 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 6.72e-04 | 11 | 71 | 2 | GO:0101020 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 8.30e-04 | 118 | 71 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | D1 dopamine receptor binding | 1.10e-03 | 14 | 71 | 2 | GO:0031748 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 1.10e-03 | 14 | 71 | 2 | GO:0008401 | |
| GeneOntologyBiologicalProcess | positive regulation of striated muscle contraction | 2.68e-05 | 17 | 72 | 3 | GO:0045989 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 3.26e-05 | 52 | 72 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | negative regulation of cholangiocyte proliferation | 3.60e-05 | 3 | 72 | 2 | GO:1904055 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 6.25e-05 | 286 | 72 | 7 | GO:0042445 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 7.34e-05 | 124 | 72 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 8.35e-05 | 66 | 72 | 4 | GO:0007019 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.35e-04 | 141 | 72 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.49e-04 | 144 | 72 | 5 | GO:0051261 | |
| Domain | ATPase_dyneun-rel_AAA | 1.78e-05 | 14 | 70 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.78e-05 | 14 | 70 | 3 | PF07728 | |
| Domain | PINCH | 4.14e-05 | 3 | 70 | 2 | IPR017351 | |
| Domain | LIM | 1.30e-04 | 69 | 70 | 4 | PF00412 | |
| Domain | Cyt_P450_E_grp-II | 1.37e-04 | 5 | 70 | 2 | IPR002402 | |
| Domain | - | 1.38e-04 | 70 | 70 | 4 | 2.10.110.10 | |
| Domain | Znf_LIM | 1.45e-04 | 71 | 70 | 4 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.45e-04 | 71 | 70 | 4 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 1.45e-04 | 71 | 70 | 4 | PS50023 | |
| Domain | LIM | 1.45e-04 | 71 | 70 | 4 | SM00132 | |
| Domain | Cyt_P450_E_CYP3A | 2.06e-04 | 6 | 70 | 2 | IPR008072 | |
| Domain | DHC_N1 | 3.82e-04 | 8 | 70 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 3.82e-04 | 8 | 70 | 2 | IPR013594 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.22e-03 | 14 | 70 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.22e-03 | 14 | 70 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.22e-03 | 14 | 70 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.22e-03 | 14 | 70 | 2 | PF08393 | |
| Domain | MT | 1.22e-03 | 14 | 70 | 2 | PF12777 | |
| Domain | AAA_8 | 1.22e-03 | 14 | 70 | 2 | PF12780 | |
| Domain | DHC_fam | 1.41e-03 | 15 | 70 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.41e-03 | 15 | 70 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.41e-03 | 15 | 70 | 2 | PF03028 | |
| Domain | AAA+_ATPase | 2.10e-03 | 144 | 70 | 4 | IPR003593 | |
| Domain | AAA | 2.10e-03 | 144 | 70 | 4 | SM00382 | |
| Domain | Apc4_WD40_dom | 2.52e-03 | 20 | 70 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 2.52e-03 | 20 | 70 | 2 | PF12894 | |
| Domain | UDPGT | 2.78e-03 | 21 | 70 | 2 | PF00201 | |
| Domain | UDPGT | 2.78e-03 | 21 | 70 | 2 | PS00375 | |
| Domain | UDP_glucos_trans | 2.78e-03 | 21 | 70 | 2 | IPR002213 | |
| Domain | TPR_REGION | 3.42e-03 | 165 | 70 | 4 | PS50293 | |
| Domain | TPR | 3.42e-03 | 165 | 70 | 4 | PS50005 | |
| Domain | C2H2_Znf_fam | 3.62e-03 | 24 | 70 | 2 | IPR027775 | |
| Domain | - | 3.93e-03 | 25 | 70 | 2 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 3.93e-03 | 25 | 70 | 2 | IPR017946 | |
| Domain | - | 6.63e-03 | 746 | 70 | 8 | 3.40.50.300 | |
| Domain | - | 7.60e-03 | 207 | 70 | 4 | 1.25.40.10 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.18e-06 | 64 | 47 | 5 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.41e-06 | 70 | 47 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.92e-06 | 72 | 47 | 5 | M9257 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.34e-05 | 44 | 47 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.46e-05 | 45 | 47 | 4 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 2.42e-05 | 51 | 47 | 4 | M17726 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 2.74e-05 | 18 | 47 | 3 | MM15123 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 2.74e-05 | 18 | 47 | 3 | M840 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 3.27e-05 | 55 | 47 | 4 | M14933 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 8.49e-05 | 220 | 47 | 6 | M10320 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 9.61e-05 | 27 | 47 | 3 | M47755 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 1.19e-04 | 29 | 47 | 3 | M2920 | |
| Pathway | WP_PDGF_PATHWAY | 3.15e-04 | 40 | 47 | 3 | M39555 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 3.86e-04 | 9 | 47 | 2 | M45020 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 3.90e-04 | 43 | 47 | 3 | M47669 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 4.35e-04 | 107 | 47 | 4 | MM14595 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 4.47e-04 | 45 | 47 | 3 | M47670 | |
| Pathway | PID_ILK_PATHWAY | 4.47e-04 | 45 | 47 | 3 | M71 | |
| Pathway | REACTOME_DRUG_ADME | 4.67e-04 | 109 | 47 | 4 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 4.67e-04 | 109 | 47 | 4 | M18788 | |
| Pathway | REACTOME_DRUG_ADME | 6.51e-04 | 119 | 47 | 4 | MM15692 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.85e-04 | 52 | 47 | 3 | M14171 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 7.03e-04 | 12 | 47 | 2 | MM14835 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 7.03e-04 | 12 | 47 | 2 | M11773 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 7.80e-04 | 219 | 47 | 5 | MM14838 | |
| Pathway | PID_FCER1_PATHWAY | 1.04e-03 | 60 | 47 | 3 | M7 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.11e-03 | 15 | 47 | 2 | MM15697 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 1.43e-03 | 17 | 47 | 2 | MM15096 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 1.43e-03 | 17 | 47 | 2 | M919 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 12167643 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 16317048 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 11331308 | ||
| Pubmed | Dissecting integrin-dependent regulation of neural stem cell proliferation in the adult brain. | 8.84e-08 | 5 | 73 | 3 | 24719101 | |
| Pubmed | 8.94e-08 | 104 | 73 | 6 | 9205841 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 23658024 | ||
| Pubmed | 3.18e-06 | 14 | 73 | 3 | 9373155 | ||
| Pubmed | 3.18e-06 | 14 | 73 | 3 | 19652092 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 28986474 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17951996 | ||
| Pubmed | Signaling via PINCH: Functions, binding partners and implications in human diseases. | 4.35e-06 | 2 | 73 | 2 | 27590440 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17656471 | ||
| Pubmed | The structural basis of integrin-linked kinase-PINCH interactions. | 4.35e-06 | 2 | 73 | 2 | 19074270 | |
| Pubmed | Structural basis of focal adhesion localization of LIM-only adaptor PINCH by integrin-linked kinase. | 4.35e-06 | 2 | 73 | 2 | 19117955 | |
| Pubmed | Focal adhesion proteins Pinch1 and Pinch2 regulate bone homeostasis in mice. | 4.35e-06 | 2 | 73 | 2 | 31723057 | |
| Pubmed | Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes. | 4.35e-06 | 2 | 73 | 2 | 15379787 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17936057 | ||
| Pubmed | LIM domain proteins Pinch1/2 regulate chondrogenesis and bone mass in mice. | 4.35e-06 | 2 | 73 | 2 | 33083097 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26772622 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 30473379 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11842224 | ||
| Pubmed | Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny. | 4.35e-06 | 2 | 73 | 2 | 26921389 | |
| Pubmed | Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. | 4.35e-06 | 2 | 73 | 2 | 11940601 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11078733 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25580742 | ||
| Pubmed | Role of ERK1/2 and PI3-K in the regulation of CTGF-induced ILK expression in HK-2 cells. | 4.35e-06 | 2 | 73 | 2 | 17498677 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21913214 | ||
| Pubmed | The focal adhesion protein PINCH-1 associates with EPLIN at integrin adhesion sites. | 4.35e-06 | 2 | 73 | 2 | 25609703 | |
| Pubmed | Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors. | 4.35e-06 | 2 | 73 | 2 | 25689036 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 27349315 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 36385586 | ||
| Pubmed | Developmental regulation of CYP3A4 and CYP3A7 in Chinese Han population. | 4.35e-06 | 2 | 73 | 2 | 27727071 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12485945 | ||
| Pubmed | Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis. | 4.35e-06 | 2 | 73 | 2 | 24058607 | |
| Pubmed | Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. | 5.91e-06 | 17 | 73 | 3 | 24737748 | |
| Pubmed | 8.39e-06 | 19 | 73 | 3 | 19349584 | ||
| Pubmed | 9.24e-06 | 493 | 73 | 8 | 15368895 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.25e-05 | 861 | 73 | 10 | 36931259 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 14551191 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 19435803 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 19801957 | ||
| Pubmed | Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. | 1.30e-05 | 3 | 73 | 2 | 23143891 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 33866277 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 10574708 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 20621111 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 15872073 | ||
| Pubmed | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. | 1.30e-05 | 3 | 73 | 2 | 20615193 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 22277676 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 29695398 | ||
| Pubmed | Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. | 1.30e-05 | 3 | 73 | 2 | 32001245 | |
| Pubmed | Brief research report: Effects of Pinch deficiency on cartilage homeostasis in adult mice. | 1.30e-05 | 3 | 73 | 2 | 36743414 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 32146629 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 12432066 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 10022929 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 27496898 | ||
| Pubmed | Synergistic role of retinoic acid signaling and Gata3 during primitive choanae formation. | 1.30e-05 | 3 | 73 | 2 | 34272563 | |
| Pubmed | ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation. | 1.30e-05 | 3 | 73 | 2 | 26460618 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 17582393 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 20118548 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 34688813 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 15563458 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.93e-05 | 262 | 73 | 6 | 36880596 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 33587032 | ||
| Pubmed | Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2. | 2.60e-05 | 4 | 73 | 2 | 9600074 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 20164304 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 26238215 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 21343177 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 34689350 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 18978522 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 15565145 | ||
| Pubmed | The roles of two distinct regions of PINCH-1 in the regulation of cell attachment and spreading. | 2.60e-05 | 4 | 73 | 2 | 20926685 | |
| Pubmed | Non-catalytic signaling by pseudokinase ILK for regulating cell adhesion. | 2.60e-05 | 4 | 73 | 2 | 30367047 | |
| Pubmed | 3.09e-05 | 285 | 73 | 6 | 21423176 | ||
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 3.33e-05 | 86 | 73 | 4 | 10862698 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 24168324 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 9593725 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 14559847 | ||
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 4.33e-05 | 5 | 73 | 2 | 11266076 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 10350061 | ||
| Pubmed | Expression of MYOSIN VIIA in developing mouse cochleovestibular ganglion neurons. | 4.33e-05 | 5 | 73 | 2 | 31918020 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 11093772 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 22767580 | ||
| Pubmed | Pathways downstream of Shc and Grb2 are required for cell transformation by the tpr-Met oncoprotein. | 4.33e-05 | 5 | 73 | 2 | 8662733 | |
| Pubmed | 5.53e-05 | 193 | 73 | 5 | 19343046 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 18339839 | ||
| Pubmed | PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions. | 6.48e-05 | 6 | 73 | 2 | 12651156 | |
| Pubmed | Interaction of smoothened with integrin-linked kinase in primary cilia mediates Hedgehog signalling. | 6.48e-05 | 6 | 73 | 2 | 23877428 | |
| Pubmed | CD99 inhibits CD98-mediated β1 integrin signaling through SHP2-mediated FAK dephosphorylation. | 6.48e-05 | 6 | 73 | 2 | 26172215 | |
| Pubmed | A PINCH-1-Smurf1 signaling axis mediates mechano-regulation of BMPR2 and stem cell differentiation. | 6.48e-05 | 6 | 73 | 2 | 31578224 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 8890167 | ||
| Pubmed | 7.19e-05 | 332 | 73 | 6 | 37433992 | ||
| Pubmed | 8.43e-05 | 497 | 73 | 7 | 23414517 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 8.53e-05 | 498 | 73 | 7 | 36634849 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 33139725 | ||
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 9.06e-05 | 7 | 73 | 2 | 11137287 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 19842932 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 25086068 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 10391903 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 28546219 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 31178125 | ||
| GeneFamily | Dyneins, axonemal | 1.66e-05 | 17 | 54 | 3 | 536 | |
| GeneFamily | LIM zinc finger domain containing|LIM domain containing | 5.23e-05 | 4 | 54 | 2 | 1163 | |
| GeneFamily | Cytochrome P450 family 3 | 2.42e-04 | 8 | 54 | 2 | 1002 | |
| GeneFamily | LIM domain containing | 7.27e-04 | 59 | 54 | 3 | 1218 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.45e-03 | 19 | 54 | 2 | 832 | |
| GeneFamily | UDP glucuronosyltransferases | 4.10e-03 | 32 | 54 | 2 | 363 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.91e-03 | 115 | 54 | 3 | 769 | |
| GeneFamily | Phospholipases | 6.98e-03 | 42 | 54 | 2 | 467 | |
| GeneFamily | PDZ domain containing | 1.06e-02 | 152 | 54 | 3 | 1220 | |
| GeneFamily | AAA ATPases | 1.09e-02 | 53 | 54 | 2 | 413 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP | 1.83e-05 | 199 | 72 | 6 | M4473 | |
| Coexpression | GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP | 1.88e-05 | 200 | 72 | 6 | M7335 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.21e-07 | 195 | 73 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.21e-07 | 195 | 73 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 9.24e-07 | 199 | 73 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 9.24e-07 | 199 | 73 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|ILC / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-06 | 61 | 73 | 4 | d0b33a48ee2faf68b270f9279c630437f3e8b20b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-06 | 155 | 73 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-06 | 155 | 73 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.37e-06 | 168 | 73 | 5 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-06 | 174 | 73 | 5 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.92e-06 | 174 | 73 | 5 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | COVID-19_Convalescent|World / Disease Group and Platelet Clusters | 1.02e-05 | 175 | 73 | 5 | e9b1faa4c85537f30306619a2f3ada6c8ef0ac6c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-05 | 181 | 73 | 5 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.48e-05 | 189 | 73 | 5 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.48e-05 | 189 | 73 | 5 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-05 | 189 | 73 | 5 | d05e043d0874b8563b9f5514f6c884b35c603e3a | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-05 | 190 | 73 | 5 | 55df73c8b696967a925b1772631f6900eff0fa30 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.52e-05 | 190 | 73 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.52e-05 | 190 | 73 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-05 | 190 | 73 | 5 | 494fbab37305a7f92cddec75b291d42282555f5f | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 190 | 73 | 5 | 8f5e71a0861ee4e8f3ce45e8a7f18fb9d6036a3c | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 190 | 73 | 5 | 84265be128170cbb08d76e824aa108e07da9c3e5 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 190 | 73 | 5 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 193 | 73 | 5 | 268925bfe85fb94a93a4ff8fe078d692df888140 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.63e-05 | 193 | 73 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 193 | 73 | 5 | ee91a796d0f6d4cee7a93a525689e716fdceeda5 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 194 | 73 | 5 | 1531dcace28a14bd700e909a027426a8cee20337 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.72e-05 | 195 | 73 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.72e-05 | 195 | 73 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-05 | 195 | 73 | 5 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.72e-05 | 195 | 73 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | tumor_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.76e-05 | 196 | 73 | 5 | 5a0b5aeff7e535781ea2a4c85799bb468afcb6f8 | |
| ToppCell | Severe-Lymphoid-T-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 1.76e-05 | 196 | 73 | 5 | 29d4db6816fead2ad9136ef824e0775463b02159 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-05 | 197 | 73 | 5 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.80e-05 | 197 | 73 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-05 | 197 | 73 | 5 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-05 | 197 | 73 | 5 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.80e-05 | 197 | 73 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-05 | 197 | 73 | 5 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.80e-05 | 197 | 73 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 197 | 73 | 5 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.85e-05 | 198 | 73 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.85e-05 | 198 | 73 | 5 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 198 | 73 | 5 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.89e-05 | 199 | 73 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.94e-05 | 200 | 73 | 5 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.78e-05 | 133 | 73 | 4 | 29b0c2c682c6b97823e7d8d8ba1f5114044b30ba | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 133 | 73 | 4 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 133 | 73 | 4 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | control-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.99e-05 | 147 | 73 | 4 | 68258498202c7f580f72c46dd645071835098455 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 148 | 73 | 4 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 148 | 73 | 4 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 149 | 73 | 4 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-04 | 151 | 73 | 4 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-04 | 151 | 73 | 4 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 154 | 73 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 154 | 73 | 4 | ec920cae12ea1d14b6c973f6e903f895f80e3c50 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 154 | 73 | 4 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-04 | 157 | 73 | 4 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-04 | 159 | 73 | 4 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-04 | 159 | 73 | 4 | b1d5ebd0c186b6d0279dab20d8f3b4a915acdc1f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-04 | 159 | 73 | 4 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-04 | 160 | 73 | 4 | 1a9329d8183296f36928bd9e96f10db9f04ce326 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 1.42e-04 | 161 | 73 | 4 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | T_cells-TFH-like_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.52e-04 | 164 | 73 | 4 | b10cf59f4cc37ca6cd0ecf71d7de278cc2bdd8b5 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 166 | 73 | 4 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 167 | 73 | 4 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 167 | 73 | 4 | 92ddabbe55315856d8ea6f8db1560b6d97636bac | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 168 | 73 | 4 | 110c3c7c322e04a684a19c2b5434a502279fd000 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 168 | 73 | 4 | 735d30cfda1889740bdeb43e39330a52e8f4d599 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 169 | 73 | 4 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 169 | 73 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 169 | 73 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 73 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 73 | 4 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 73 | 4 | aff226a84e397ab58204325aa9d8b396a881986e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 73 | 4 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 73 | 4 | 6af16e6f276aec6389ece99505ba13c7edc4c4fa | |
| ToppCell | control-dn_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.75e-04 | 170 | 73 | 4 | 839f62860b4a52d06e6a8fce7632195c7310b89d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.79e-04 | 171 | 73 | 4 | e6dfbd2652b67577c8834c05348f62150637f348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.79e-04 | 171 | 73 | 4 | ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.79e-04 | 171 | 73 | 4 | e1fe07652c10c37191d1471ddaea500f74269e0c | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 173 | 73 | 4 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.87e-04 | 173 | 73 | 4 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-04 | 175 | 73 | 4 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 175 | 73 | 4 | 8252ddc2ca95071381f0354aefb70c4714828491 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-04 | 175 | 73 | 4 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 175 | 73 | 4 | 8ccf60fc469059d7aaf4e6ce54159db2962e0060 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.00e-04 | 176 | 73 | 4 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 176 | 73 | 4 | a23d484aff5ad094333b2feae9106ca219514711 | |
| ToppCell | droplet-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 177 | 73 | 4 | a5b54792ef948a1e1de66301a60e051250189f59 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-04 | 177 | 73 | 4 | 9edfb50856f5e10672ab194ce0076d6a190e64de | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 178 | 73 | 4 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 178 | 73 | 4 | 5cc182e6faa7ba5b88378d2c953be29bbbb95a7e | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 178 | 73 | 4 | f9a16bc3f09c35c7d30e3809da024bc2dcf746ed | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 178 | 73 | 4 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.08e-04 | 178 | 73 | 4 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-04 | 179 | 73 | 4 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-04 | 180 | 73 | 4 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 180 | 73 | 4 | 407fd8f61a757626e082b6e2eefd3a33276e6b71 | |
| ToppCell | facs-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.22e-04 | 181 | 73 | 4 | 72c28baf4fd417ff4a7068603830d55074960144 | |
| Drug | beta-naphthoflavone | 3.30e-06 | 200 | 72 | 7 | CID000002361 | |
| Drug | Biliton | 8.52e-06 | 41 | 72 | 4 | CID000002974 | |
| Drug | orthovanadate | 9.17e-06 | 435 | 72 | 9 | CID000061672 | |
| Drug | p-nitroanisole | 1.09e-05 | 92 | 72 | 5 | CID000007485 | |
| Drug | N'-nitrosonornicotine | 1.34e-05 | 15 | 72 | 3 | ctd:C008655 | |
| Drug | 1-naphthol | 1.48e-05 | 98 | 72 | 5 | CID000007005 | |
| Drug | geldanamycin | 2.22e-05 | 371 | 72 | 8 | ctd:C001277 | |
| Drug | SN-38 | 2.58e-05 | 184 | 72 | 6 | CID000104842 | |
| Drug | 5,6-epoxy-8,11,14-eicosatrienoic acid | 2.95e-05 | 3 | 72 | 2 | ctd:C040776 | |
| Drug | 17-hydroxypregnenolone sulfate | 2.95e-05 | 3 | 72 | 2 | CID000152971 | |
| Drug | AC1L1FTZ | 2.95e-05 | 3 | 72 | 2 | CID000003392 | |
| Drug | SN-38G | 3.67e-05 | 59 | 72 | 4 | CID000443154 | |
| Drug | benzphetamine | 3.79e-05 | 119 | 72 | 5 | CID000002341 | |
| Drug | hexobarbital | 5.18e-05 | 127 | 72 | 5 | CID000003608 | |
| Drug | vanadyl | 5.27e-05 | 307 | 72 | 7 | CID000061671 | |
| Drug | Aroclor 1254 | 5.84e-05 | 213 | 72 | 6 | CID000040470 | |
| Drug | 5,6-epoxyeicosatrienoic acid | 6.42e-05 | 68 | 72 | 4 | CID000001778 | |
| Disease | apolipoprotein B measurement | 2.65e-05 | 663 | 70 | 9 | EFO_0004615 | |
| Disease | tacrolimus measurement | 3.32e-05 | 4 | 70 | 2 | EFO_0008458 | |
| Disease | estrone conjugate measurement | 3.32e-05 | 4 | 70 | 2 | EFO_0007971 | |
| Disease | tauro-beta-muricholate measurement | 5.52e-05 | 5 | 70 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 5.52e-05 | 5 | 70 | 2 | EFO_0800569 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 8.27e-05 | 6 | 70 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 8.27e-05 | 6 | 70 | 2 | EFO_0800294 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 9.22e-05 | 99 | 70 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.04e-04 | 102 | 70 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | X-24574 measurement | 1.16e-04 | 7 | 70 | 2 | EFO_0800897 | |
| Disease | fibromuscular dysplasia | 1.58e-04 | 44 | 70 | 3 | EFO_1000938 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 1.98e-04 | 9 | 70 | 2 | EFO_0800278 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 2.47e-04 | 10 | 70 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 2.47e-04 | 10 | 70 | 2 | EFO_0800289 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 3.01e-04 | 11 | 70 | 2 | EFO_0801531 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 3.01e-04 | 11 | 70 | 2 | EFO_0800295 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3.61e-04 | 12 | 70 | 2 | C0023485 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 3.61e-04 | 12 | 70 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 4.25e-04 | 13 | 70 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 4.25e-04 | 13 | 70 | 2 | EFO_0800284 | |
| Disease | Liver Cirrhosis, Experimental | 4.86e-04 | 774 | 70 | 8 | C0023893 | |
| Disease | X-21470 measurement | 4.96e-04 | 14 | 70 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 4.96e-04 | 14 | 70 | 2 | EFO_0800283 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 5.26e-04 | 66 | 70 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 5.71e-04 | 15 | 70 | 2 | EFO_0800301 | |
| Disease | X-21410 measurement | 6.52e-04 | 16 | 70 | 2 | EFO_0800813 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 6.52e-04 | 16 | 70 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 6.52e-04 | 16 | 70 | 2 | EFO_0800305 | |
| Disease | anthranilic acid measurement | 6.52e-04 | 16 | 70 | 2 | EFO_0010460 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 8.28e-04 | 18 | 70 | 2 | EFO_0800288 | |
| Disease | Lung diseases | 8.56e-04 | 78 | 70 | 3 | C0024115 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 9.24e-04 | 19 | 70 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | metabolonic lactone sulfate measurement | 9.24e-04 | 19 | 70 | 2 | EFO_0800659 | |
| Disease | etiocholanolone glucuronide measurement | 9.24e-04 | 19 | 70 | 2 | EFO_0800362 | |
| Disease | androsterone glucuronide measurement | 1.03e-03 | 20 | 70 | 2 | EFO_0800317 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.08e-03 | 189 | 70 | 4 | EFO_0009932 | |
| Disease | X-24947 measurement | 1.24e-03 | 22 | 70 | 2 | EFO_0800910 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 1.24e-03 | 22 | 70 | 2 | EFO_0021115 | |
| Disease | epiandrosterone sulfate measurement | 1.61e-03 | 25 | 70 | 2 | EFO_0021120 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.73e-03 | 215 | 70 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | C-reactive protein measurement | 2.14e-03 | 1206 | 70 | 9 | EFO_0004458 | |
| Disease | Ciliopathies | 2.30e-03 | 110 | 70 | 3 | C4277690 | |
| Disease | lymphocyte count | CYP3A7 LIMA1 DNAH10 CYP3A4 AHNAK DNAH17 GATA3 ERCC6L2 RNF212B LIMS2 | 2.30e-03 | 1464 | 70 | 10 | EFO_0004587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VNFPSFLPAFVKKMK | 206 | Q7Z4L5 | |
| PKPLCFMEVLAKEDT | 26 | P0C875 | |
| LNCKMKFAVYLPPKA | 26 | P10768 | |
| PKLMEVCKEKDFSPE | 171 | O15372 | |
| MAKKPDCLEKVYQLP | 226 | Q9BYD9 | |
| KMFAVDAKALPQNKP | 416 | Q7Z2Z2 | |
| TKQIMLVKKEFPYPC | 91 | P12544 | |
| KELACPMPVIFAKAT | 4451 | Q96DT5 | |
| LECPDAKLKGPKFKM | 1831 | Q09666 | |
| FCILFAPKAAMQEKE | 1491 | Q96BY7 | |
| NLKPQEKMFFKSPVE | 51 | A8MTL3 | |
| KMPFINIPVLDIKKC | 391 | O95980 | |
| FKFMKKFEAVLSEPC | 3971 | Q9NU22 | |
| TLKNKFVEFDMKPVC | 291 | Q7Z4I7 | |
| PKAMKKFQAPARETC | 376 | Q9UHB6 | |
| KLLPDDPYEKACQKM | 101 | P78417 | |
| KISDPDLFKMIKFCL | 1526 | O15054 | |
| VCKKDVEINGMFIPK | 376 | P08684 | |
| KKEKSEMVPSCPFIY | 41 | Q9BW27 | |
| NFTCPITKEEMKKPV | 166 | Q96MF7 | |
| EKDFCPMDRKPLVLQ | 71 | Q8TBB1 | |
| NFPFIKICSPDKMIG | 561 | P46459 | |
| KKCKAANPEMPLSFT | 186 | Q7L5L3 | |
| MPEFETKCNNSKPKK | 311 | Q06124 | |
| PLKRKCEMETEYQPK | 201 | Q96E09 | |
| MICSIQDDVPFKLKP | 381 | Q9Y5E8 | |
| VGKIMKFKPDCVNVE | 976 | O00410 | |
| PPQMKKKCVNGFIMF | 536 | C9JSJ3 | |
| FMCNTVFKKIPLKPS | 391 | A2A3N6 | |
| KECLKYQVPLPDSMK | 181 | P23771 | |
| CVNMKLFFKDKEPVP | 391 | Q9UFH2 | |
| EIMPDVQDPKFAKCF | 1326 | Q5T9S5 | |
| LPVEFKCPDGEVMKK | 301 | P29279 | |
| VSSPPMFVLDKKCEK | 371 | Q9P2H0 | |
| TFLPEVAKKFPNMKI | 331 | P17213 | |
| KICMNEDPAKRPKFD | 426 | Q13418 | |
| YVSDKKKDMSPPFIC | 701 | Q8NDI1 | |
| EDKEDNLCPVLKPKM | 1696 | O15021 | |
| KDKIFVVKMNPYVPD | 816 | Q05BV3 | |
| VCKKDVEINGMFIPK | 376 | P24462 | |
| FIPRKPMKCSNEKVV | 1096 | Q5T890 | |
| IVMEKFAAKKPPCVA | 1006 | Q8IVF4 | |
| PAFNKFVLMKAVEPK | 506 | Q9Y467 | |
| MLPEKLFIPNDFFKK | 3551 | Q9NZJ4 | |
| GLKECYVFKPKNPDM | 616 | P47712 | |
| YVFKPKNPDMEKDCP | 621 | P47712 | |
| LKKFQPDLKERFCMN | 2021 | P56715 | |
| FSKTNMVDLCPKVPK | 971 | Q9BQF6 | |
| VMVNDKPVCKPCYVK | 341 | Q9UGI8 | |
| NTCPLPQEMKALFKK | 131 | Q96T21 | |
| TLKNKFVEFDMKPVC | 286 | P48059 | |
| MKPVCKKCYEKFPLE | 296 | P48059 | |
| PLKPDYCVKQAMKAI | 266 | Q8IZV5 | |
| MEDVKLEFPSLPQCK | 1 | Q8WUJ0 | |
| PISMENPYKEPLKKC | 51 | Q9Y3D5 | |
| PPSKVFVCDKPESMK | 346 | Q96JQ2 | |
| PKPMEFRACYIKVKI | 946 | O75339 | |
| EVTYKMCSIPPKNEK | 106 | Q9Y2V2 | |
| QFIQPLECMEKFDKK | 66 | O94967 | |
| MKLFLDCLKEFPEKQ | 571 | Q7Z7L7 | |
| FPTMLKECSPKKDQK | 701 | Q6ZU65 | |
| FFPKEMPKEKRELQF | 296 | O94956 | |
| FSPKEPDCFKDIVNM | 751 | P11216 | |
| KMLLEKFVEECKFPP | 631 | P53804 | |
| ANPMPTFKCAVKALF | 786 | P19174 | |
| FLKCVMPNKTELLKP | 1106 | Q6AHZ1 | |
| MDKCFPEKNKPGEIA | 286 | Q99986 | |
| KPAKALPKEMENFVQ | 281 | Q6UWM9 | |
| CKPAKPLPKEMEEFV | 281 | P36537 | |
| PFVFICKNPQEMVVK | 536 | Q15650 | |
| CKNPQEMVVKFPIKG | 541 | Q15650 | |
| NPMACKEILKPNYKS | 2241 | O15050 | |
| FTNIKDLFMKKCPGV | 526 | Q9HBA0 | |
| FIKPKQPMDSKEGCE | 126 | Q9HCK0 | |
| PKEYQKDVVCIPNKM | 281 | Q9C0D4 | |
| FFVRCIKPNEFKKPM | 631 | Q13402 |